1. Home
  2. LUNR vs KNSA Comparison

LUNR vs KNSA Comparison

Compare LUNR & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$37.64

Market Cap

3.9B

Sector

Industrials

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$53.39

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUNR
KNSA
Founded
2013
2015
Country
United States
United Kingdom
Employees
525
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LUNR
KNSA
Price
$37.64
$53.39
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
$22.35
$60.86
AVG Volume (30 Days)
10.2M
695.9K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
225.00
EPS
N/A
0.27
Revenue
N/A
$677,564,000.00
Revenue This Year
$343.00
$37.48
Revenue Next Year
$16.81
$17.87
P/E Ratio
N/A
$197.56
Revenue Growth
N/A
60.09
52 Week Low
$7.78
$26.27
52 Week High
$38.55
$59.87

Technical Indicators

Market Signals
Indicator
LUNR
KNSA
Relative Strength Index (RSI) 69.46 50.44
Support Level $15.87 $40.67
Resistance Level N/A $59.87
Average True Range (ATR) 3.88 2.10
MACD 0.40 -0.76
Stochastic Oscillator 94.91 13.23

Price Performance

Historical Comparison
LUNR
KNSA

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space infrastructure and services company focused on enabling sustained human activity beyond Earth. It designs, builds, integrates, and operates space systems, offering infrastructure-as-a-service across low Earth orbit, geostationary orbit, cislunar space, and deep space. Its capabilities include spacecraft development and space-based network connectivity, serving commercial, civil, and national security customers. The company conducts sales both directly and through an extensive customer and partner network spanning North America, South America, Europe, Asia, and Australia, including rideshare delivery providers, lunar surface mobility providers, payload providers, communication satellite providers, and ground segment providers.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: